Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Neurodegenerative and neuropsychological disorders are becoming a greater proportion of the global disease burden; however the pathogenic mechanisms by which these disorders originate and contribute to disease progression are not well-described. Increasing evidence supports neuroinflammation as a common underlying component associated with the neuropathological processes that effect disease progression. This collection of articles explores the role of adaptive immunity in autoimmunity, neurodegeneration, neurotrauma, and psychological disorders. The section emphasizes the interactions of T cells with innate cellular responses within the CNS and the effects on neurological functions. One recurrent theme is that modified and aggregated self-proteins upregulate innate-mediated inflammation and provide a permissive environment for polarization of T cells to proinflammatory effector cells. Moreover, infiltration and reactivation of those T effector cells exacerbate neuroinflammation and oxidative stress to greater neurotoxic levels. Another recurrent theme in these disorders promotes diminished regulatory functions that reduce control over activated T effector cells and microglia, and ultimately augment proinflammatory conditions. Augmentation of regulatory control is discussed as therapeutic strategies to attenuate neuroinflammation, mitigate neurodegeneration or neuronal dysfunction, and lessen disease progression.

Original languageEnglish (US)
Pages (from-to)522-527
Number of pages6
JournalJournal of Neuroimmune Pharmacology
Volume10
Issue number4
DOIs
StatePublished - Dec 1 2015

Fingerprint

Adaptive Immunity
Neurodegenerative Diseases
Disease Progression
T-Lymphocytes
Microglia
Autoimmunity
Oxidative Stress
Up-Regulation
Psychology
Inflammation
Proteins
Therapeutics

Keywords

  • Adaptive immunity
  • Innate immunity
  • Neurodegeneration
  • Neuropsychological disorders

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders. / Mosley, R Lee.

In: Journal of Neuroimmune Pharmacology, Vol. 10, No. 4, 01.12.2015, p. 522-527.

Research output: Contribution to journalArticle

@article{64f86fc09bc5492cb4944517dbed3c8b,
title = "Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders",
abstract = "Neurodegenerative and neuropsychological disorders are becoming a greater proportion of the global disease burden; however the pathogenic mechanisms by which these disorders originate and contribute to disease progression are not well-described. Increasing evidence supports neuroinflammation as a common underlying component associated with the neuropathological processes that effect disease progression. This collection of articles explores the role of adaptive immunity in autoimmunity, neurodegeneration, neurotrauma, and psychological disorders. The section emphasizes the interactions of T cells with innate cellular responses within the CNS and the effects on neurological functions. One recurrent theme is that modified and aggregated self-proteins upregulate innate-mediated inflammation and provide a permissive environment for polarization of T cells to proinflammatory effector cells. Moreover, infiltration and reactivation of those T effector cells exacerbate neuroinflammation and oxidative stress to greater neurotoxic levels. Another recurrent theme in these disorders promotes diminished regulatory functions that reduce control over activated T effector cells and microglia, and ultimately augment proinflammatory conditions. Augmentation of regulatory control is discussed as therapeutic strategies to attenuate neuroinflammation, mitigate neurodegeneration or neuronal dysfunction, and lessen disease progression.",
keywords = "Adaptive immunity, Innate immunity, Neurodegeneration, Neuropsychological disorders",
author = "Mosley, {R Lee}",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s11481-015-9640-y",
language = "English (US)",
volume = "10",
pages = "522--527",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders

AU - Mosley, R Lee

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Neurodegenerative and neuropsychological disorders are becoming a greater proportion of the global disease burden; however the pathogenic mechanisms by which these disorders originate and contribute to disease progression are not well-described. Increasing evidence supports neuroinflammation as a common underlying component associated with the neuropathological processes that effect disease progression. This collection of articles explores the role of adaptive immunity in autoimmunity, neurodegeneration, neurotrauma, and psychological disorders. The section emphasizes the interactions of T cells with innate cellular responses within the CNS and the effects on neurological functions. One recurrent theme is that modified and aggregated self-proteins upregulate innate-mediated inflammation and provide a permissive environment for polarization of T cells to proinflammatory effector cells. Moreover, infiltration and reactivation of those T effector cells exacerbate neuroinflammation and oxidative stress to greater neurotoxic levels. Another recurrent theme in these disorders promotes diminished regulatory functions that reduce control over activated T effector cells and microglia, and ultimately augment proinflammatory conditions. Augmentation of regulatory control is discussed as therapeutic strategies to attenuate neuroinflammation, mitigate neurodegeneration or neuronal dysfunction, and lessen disease progression.

AB - Neurodegenerative and neuropsychological disorders are becoming a greater proportion of the global disease burden; however the pathogenic mechanisms by which these disorders originate and contribute to disease progression are not well-described. Increasing evidence supports neuroinflammation as a common underlying component associated with the neuropathological processes that effect disease progression. This collection of articles explores the role of adaptive immunity in autoimmunity, neurodegeneration, neurotrauma, and psychological disorders. The section emphasizes the interactions of T cells with innate cellular responses within the CNS and the effects on neurological functions. One recurrent theme is that modified and aggregated self-proteins upregulate innate-mediated inflammation and provide a permissive environment for polarization of T cells to proinflammatory effector cells. Moreover, infiltration and reactivation of those T effector cells exacerbate neuroinflammation and oxidative stress to greater neurotoxic levels. Another recurrent theme in these disorders promotes diminished regulatory functions that reduce control over activated T effector cells and microglia, and ultimately augment proinflammatory conditions. Augmentation of regulatory control is discussed as therapeutic strategies to attenuate neuroinflammation, mitigate neurodegeneration or neuronal dysfunction, and lessen disease progression.

KW - Adaptive immunity

KW - Innate immunity

KW - Neurodegeneration

KW - Neuropsychological disorders

UR - http://www.scopus.com/inward/record.url?scp=84948564702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948564702&partnerID=8YFLogxK

U2 - 10.1007/s11481-015-9640-y

DO - 10.1007/s11481-015-9640-y

M3 - Article

C2 - 26496777

AN - SCOPUS:84948564702

VL - 10

SP - 522

EP - 527

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 4

ER -